|
ATE1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.50826051437525E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03249997440713E-09 |
| Normal-vs-Stage2 |
5.84009999999857E-05 |
| Normal-vs-Stage3 |
3.36559669023018E-11 |
| Normal-vs-Stage4 |
3.38709948977112E-10 |
| Stage1-vs-Stage2 |
5.753000E-01 |
| Stage1-vs-Stage3 |
1.606840E-01 |
| Stage1-vs-Stage4 |
4.854200E-02 |
| Stage2-vs-Stage3 |
1.320980E-01 |
| Stage2-vs-Stage4 |
6.799800E-02 |
| Stage3-vs-Stage4 |
5.270200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.54907206453936E-13 |
| Normal-vs-AfricanAmerican |
5.979200E-03 |
| Normal-vs-Asian |
8.34619999778852E-08 |
| Caucasian-vs-AfricanAmerican |
6.695900E-02 |
| Caucasian-vs-Asian |
9.322800E-01 |
| AfricanAmerican-vs-Asian |
1.113960E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.1282754164863E-12 |
| Normal-vs-Female |
2.00840011288506E-10 |
| Male-vs-Female |
7.665700E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.25819998442989E-09 |
| Normal-vs-Age(41-60Yrs) |
1.1020961920849E-11 |
| Normal-vs-Age(61-80Yrs) |
3.02879999969363E-08 |
| Normal-vs-Age(81-100Yrs) |
1.675300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.148600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.624600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.827800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.683000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.402400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.151600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.541400E-03 |
| Classical-VS-Follicular |
5.304800E-01 |
| Classical-VS-Other |
1.162750E-01 |
| Classical-VS-Normal |
1.23010046593208E-10 |
| Tall-VS-Follicular |
1.120150E-02 |
| Tall-VS-Other |
4.390800E-01 |
| Tall-VS-Normal |
1.40130018699836E-10 |
| Follicular-VS-Other |
1.228650E-01 |
| Follicular-VS-Normal |
3.36830000002841E-06 |
| Other-VS-Normal |
1.819310E-04 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.25000051712732E-10 |
| Normal-vs-N1 |
1.71699998663399E-09 |
| N0-vs-N1 |
1.358600E-01 |
|
|
